We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Hints at Heightened Scrutiny of ‘Rebate Walls’
FTC Hints at Heightened Scrutiny of ‘Rebate Walls’
At the behest of Congress, the Federal Trade Commission (FTC) has issued a report on a drug industry tactic that involves leveraging rebates to block competing products, suggesting that the agency may be viewing the anticompetitive practice as a growing area of concern.